Pharmacogenetic analysis of drug metabolism
Berlin, September 25, 2012 – ATLAS Biolabs announces its accreditation as a certified Affymetrix DMET™ Service Provider, offering the latest DMET™ Plus Solution from Affymetrix. DMET Plus uses microarray testing to investigate common variations in genes encoding for drug-metabolism enzymes and drug transporters, and to identify their impact on the individual metabolic capacity. ATLAS Biolabs is the first European Certified Service Provider to offer the DMET technology for use in molecular pharmacogenetics in Germany.… mehr “ATLAS Biolabs is awarded Certified Service Provider Accreditation from Affymetrix for DMET analysis”